Form 4 for GKOS GLAUKOS Corp

Accepted 2024-01-18 00:00:00 ET · period of report 2024-01-16 · accession 0001415889-24-001532 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-01-18	2024-01-16	GKOS	Gilliam Joseph E	Pres, COO	M - OptEx	$30.92	+4,890	124.7K	+4%	+$151.2K
D	2024-01-18	2024-01-16	GKOS	Gilliam Joseph E	Pres, COO	S - Sale+OE	$89.17	-4,890	119.8K	-4%	-$436.0K
D	2024-01-18	2024-01-16	GKOS	Gilliam Joseph E	Pres, COO	M - OptEx	$0.00	-4,890	13.4K	-27%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-01-16	M	A	4,890	$30.92	124,692	D	—	—	(F1) Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person.
2	Common	Common Stock	2024-01-16	S	D	4,890	$89.17	119,802	D	—	—	(F3) This transaction was executed in multiple trades at prices ranging from $89.01 to $89.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F1) Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person.
3	Derivative	Stock Option (Right to Buy)	2024-01-16	M	D	4,890	$0.00	13,437	D	$30.92 · — to 2028-03-14	4,890 Common Stock	(F5) This option was granted on March 14, 2018 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date.